Pharmacy Department, Hospital Universitario Ramón y Cajal, Madrid. Spain.
Pharmacy Department, Hospital General Mateu Orfila, Mahón, Menorca. Spain.
Farm Hosp. 2022 Nov 13;46(6):340-345.
This study reports on the results of a project conducted by the Spanish Society of Hospital Pharmacy with patients with immune-mediated inflammatory diseases, with the following objectives: to understand the experience of patients living with these diseases and the role of healthcare workers in such experience, and to identify opportunities to promote or boost humanization in hospital pharmacy units.
A user-centered design methodology was used, implementing exploratory and qualitative research tools. Led by a managing team made up of experts in the methodology, a variety of people participated in this project. The team comprised representatives of patients with immunemediated inflammatory diseases, healthcare workers responsible for their care, members of the immune-mediated inflammatory disease working group of the Spanish Society of Hospital Pharmacy, and members of two patient advocacy organizations (Spanish Association of Persons with Chronic Immune-Mediated Inflammatory Diseases and the Spanish association of Patients with Psoriasis). The research tools used included indepth interviews, patients' diaries, ethnographic studies, and co-creation workshops.
Five initiatives were identified as best practices to be implemented: The creation of functional or comprehensive care units; shared medical records; integration of patient-reported outcomes with patient experiences; implementation of the "capacity, motivation, opportunity" pharmaceutical care model; and a closer interaction with patient advocacy organizations. Six opportunities to improve the current situation were selected as priority areas for hospital pharmacy departments: spreading knowledge about immune-mediated inflammatory diseases; promoting a multidisciplinary approach to these diseases; generating awareness on the role of hospital pharmacists; revisiting the internal organization of pharmacy departments; establishing closer relationships with patients; and seeing things from the patients' point of view. Ten smart humanization initiatives were proposed and classified in an impact-effort matrix: "Demystifying IMID", "IMID teen challenge", "Patient‑care academy", "Satellite consultation", "IMID network", "A click away from the pharmacy", Medicines poker", "Patient-to- patient consultation", "Pharma-friendly consultation", and "Patient-centered IMID sessions".
This Annex to the Spanish Society of Hospital Pharmacy's Guidelines for the Humanization of Hospital Pharmacy Units intends to promote a humanizing culture, bringing to the fore the unique value of every single patient suffering from an immune-mediated inflammatory disease, including their family and friends and their beliefs and needs, preserving their dignity.
本研究报告了西班牙医院药学学会与免疫介导性炎症疾病患者合作开展的一个项目的结果,其目的如下:了解患有此类疾病患者的体验以及医护人员在该体验中的作用,并确定在医院药学部门促进或增强人性化服务的机会。
采用以用户为中心的设计方法,实施了探索性和定性研究工具。该项目由一个由方法论专家组成的管理团队领导,有多名人员参与其中。该团队由免疫介导性炎症疾病患者代表、负责其护理的医护人员、西班牙医院药学学会免疫介导性炎症疾病工作组的成员以及两个患者权益倡导组织(西班牙慢性免疫介导性炎症疾病患者协会和西班牙银屑病患者协会)的成员组成。所使用的研究工具包括深入访谈、患者日记、民族志研究和共同创作研讨会。
确定了五项最佳实践举措作为实施重点:创建功能或综合护理单元;共享病历;将患者报告的结果与患者体验相结合;实施“能力、动机、机会”药物治疗模式;与患者权益倡导组织更密切地互动。选择了六个改善现状的机会作为医院药学部门的优先领域:传播免疫介导性炎症疾病知识;促进对这些疾病的多学科方法;提高对医院药师作用的认识;重新审视药房部门的内部组织;与患者建立更密切的关系;从患者的角度看问题。提出并分类了十个智能人性化举措,并将其列入影响-努力矩阵:“揭开 IMID 的神秘面纱”、“IMID 青少年挑战”、“患者护理学院”、“卫星咨询”、“IMID 网络”、“点击 Pharmacy”、“药物扑克”、“患者间咨询”、“药师友好咨询”和“以患者为中心的 IMID 会议”。
本附件旨在促进医院药学人性化服务文化,突出每个患有免疫介导性炎症疾病的患者的独特价值,包括其家人和朋友的独特价值以及他们的信仰和需求,维护他们的尊严。